General Information of This Antigen (ID: TAR0SDULL)
Antigen Name
Mast/stem cell growth factor receptor Kit (KIT)
Gene Name
KIT
Gene ID
3815
Synonym
SCFR; Piebald trait protein;Proto-oncogene c-Kit;Tyrosine-protein kinase Kit;p145 c-kit;v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog;CD117
Sequence
MRGARGAWDFLCVLLLLLRVQTGSSQPSVSPGEPSPPSIHPGKSDLIVRVGDEIRLLCTD
PGFVKWTFEILDETNENKQNEWITEKAEATNTGKYTCTNKHGLSNSIYVFVRDPAKLFLV
DRSLYGKEDNDTLVRCPLTDPEVTNYSLKGCQGKPLPKDLRFIPDPKAGIMIKSVKRAYH
RLCLHCSVDQEGKSVLSEKFILKVRPAFKAVPVVSVSKASYLLREGEEFTVTCTIKDVSS
SVYSTWKRENSQTKLQEKYNSWHHGDFNYERQATLTISSARVNDSGVFMCYANNTFGSAN
VTTTLEVVDKGFINIFPMINTTVFVNDGENVDLIVEYEAFPKPEHQQWIYMNRTFTDKWE
DYPKSENESNIRYVSELHLTRLKGTEGGTYTFLVSNSDVNAAIAFNVYVNTKPEILTYDR
LVNGMLQCVAAGFPEPTIDWYFCPGTEQRCSASVLPVDVQTLNSSGPPFGKLVVQSSIDS
SAFKHNGTVECKAYNDVGKTSAYFNFAFKGNNKEQIHPHTLFTPLLIGFVIVAGMMCIIV
MILTYKYLQKPMYEVQWKVVEEINGNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAF
GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC
TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKQEDHAEAALYKNLLHSKESSCSDSTNE
YMDMKPGVSYVVPTKADKRRSVRIGSYIERDVTPAIMEDDELALDLEDLLSFSYQVAKGM
AFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPES
IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY
DIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHIYSNLANCSPNRQKPVVDHSVRINSV
GSTASSSQPLLVHDDV

    Click to Show/Hide
Family
Tyr protein family
Function
Tyrosine-protein kinase that acts as cell-surface receptor for the cytokine KITLG/SCF and plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. In response to KITLG/SCF binding, KIT can activate several signaling pathways. Phosphorylates PIK3R1, PLCG1, SH2B2/APS and CBL. Activates the AKT1 signaling pathway by phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase. Activated KIT also transmits signals via GRB2 and activation of RAS, RAF1 and the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3, STAT5A and STAT5B. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5- trisphosphate. KIT signaling is modulated by protein phosphatases, and by rapid internalization and degradation of the receptor. Activated KIT promotes phosphorylation of the protein phosphatases PTPN6/SHP-1 and PTPRU, and of the transcription factors STAT1, STAT3, STAT5A and STAT5B. Promotes phosphorylation of PIK3R1, CBL, CRK (isoform Crk-II), LYN, MAPK1/ERK2 and/or MAPK3/ERK1, PLCG1, SRC and SHC1.

    Click to Show/Hide
Uniprot Entry
KIT_HUMAN
HGNC ID
HGNC:6342
KEGG ID
hsa:3815
Each Antibody-drug Conjugate and Its Component Related to This Antigen
Full List of The ADC Related to This Antigen
The Numbers of ADCs, Their Three Components, Payload Targets, and Corresponding Diseases for This Antigens
Anti-cKIT F (ab')2
ADC Name Payload Target Linker ADC Info
TWI852077B-J12 [1]
TWI852077B-C4-payload
Microtubule (MT)
TWI852077B-C4-linker
Anti-cKIT F (ab'3)2
ADC Name Payload Target Linker ADC Info
TWI852077B-J10 [1]
Undisclosed
Undisclosed
Undisclosed
Anti-cKIT F (ab'4)2
ADC Name Payload Target Linker ADC Info
TWI852077B-J9 [1]
TWI852077B-C4-payload
Microtubule (MT)
TWI852077B-C4-linker
Anti-cKIT Fab'1
ADC Name Payload Target Linker ADC Info
TWI852077B-J1 [1]
Monomethyl auristatin E
Microtubule (MT)
TWI852077B-C1-linker
TWI852077B-J14 [1]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
TWI852077B-J15 [1]
Undisclosed
Undisclosed
Undisclosed
TWI852077B-J16 [1]
Monomethyl auristatin E
Microtubule (MT)
TWI852077B-C1-linker
Anti-cKIT Fab'2
ADC Name Payload Target Linker ADC Info
TWI852077B-J2 [1]
Monomethyl auristatin E
Microtubule (MT)
TWI852077B-C1-linker
TWI852077B-J17 [1]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
TWI852077B-J18 [1]
Undisclosed
Undisclosed
Undisclosed
TWI852077B-J19 [1]
Monomethyl auristatin E
Microtubule (MT)
TWI852077B-C1-linker
TWI852077B-JW [1]
Monomethyl auristatin E
Microtubule (MT)
TWI852077B-C1-linker
TWI852078B-JX [1]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-cKIT Fab'3
ADC Name Payload Target Linker ADC Info
TWI852077B-J3 [1]
Monomethyl auristatin E
Microtubule (MT)
TWI852077B-C1-linker
TWI852077B-J20 [1]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
TWI852077B-J21 [1]
Undisclosed
Undisclosed
Undisclosed
TWI852077B-J22 [1]
Monomethyl auristatin E
Microtubule (MT)
TWI852077B-C1-linker
TWI852079B-JY [1]
Monomethyl auristatin E
Microtubule (MT)
TWI852077B-C1-linker
TWI852080B-JZ [1]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-cKIT Fab'4
ADC Name Payload Target Linker ADC Info
TWI852077B-J4 [1]
Monomethyl auristatin E
Microtubule (MT)
TWI852077B-C1-linker
Anti-cKIT Fab'5
ADC Name Payload Target Linker ADC Info
TWI852077B-J5 [1]
Monomethyl auristatin E
Microtubule (MT)
TWI852077B-C1-linker
TWI852077B-J23 [1]
Monomethyl auristatin E
Microtubule (MT)
TWI852077B-C1-linker
TWI852077B-J24 [1]
Monomethyl auristatin E
Microtubule (MT)
TWI852077B-C1-linker
TWI852077B-J25 [1]
Monomethyl auristatin F
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-cKIT Fab3
ADC Name Payload Target Linker ADC Info
TWI852077B-J7 [1]
Undisclosed
Undisclosed
Undisclosed
TWI852077B-J11 [1]
TWI852077B-C4-payload
Microtubule (MT)
TWI852077B-C4-linker
Anti-KIT mAb 20376
ADC Name Payload Target Linker ADC Info
Anti-KIT 20376-SMCC-DM1 [2]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Anti-KIT 20376-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
Anti-KIT 20376-CX1-1-DM1 [2]
Mertansine DM1
Microtubule (MT)
2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)
Anti-KIT 20376-SSNPP-DM3 [2]
Maytansinoid DM3
Microtubule (MT)
Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)
Anti-KIT 20376-SPP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
Anti-KIT 20376-SPDP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)
Anti-KIT 20376 Sulfo-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
Sulfo-SPDB
Anti-KIT mAb 2G4
ADC Name Payload Target Linker ADC Info
2G4-DM1 [3]
Mertansine DM1
Microtubule (MT)
Undisclosed
Anti-KIT mAb 4C9
ADC Name Payload Target Linker ADC Info
4C9-DM1 [4]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Anti-KIT mAb 9P3
ADC Name Payload Target Linker ADC Info
Anti-KIT 9P3-SMCC-DM1 [2]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Anti-KIT 9P3-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
Anti-KIT 9P3-CX1-1-DM1 [2]
Mertansine DM1
Microtubule (MT)
2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)
Anti-KIT 9P3-SSNPP-DM3 [2]
Maytansinoid DM3
Microtubule (MT)
Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)
Anti-KIT 9P3-SPP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
Anti-KIT 9P3-SPDP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)
Anti-KIT 9P3 Sulfo-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
Sulfo-SPDB
Anti-KIT mAb NEG024
ADC Name Payload Target Linker ADC Info
Anti-KIT NEG024-SMCC-DM1 [2]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Anti-KIT NEG024-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
Anti-KIT NEG024-CX1-1-DM1 [2]
Mertansine DM1
Microtubule (MT)
2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)
Anti-KIT NEG024-SSNPP-DM3 [2]
Maytansinoid DM3
Microtubule (MT)
Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)
Anti-KIT NEG024-SPP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
Anti-KIT NEG024-SPDP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)
Anti-KIT NEG024 Sulfo-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
Sulfo-SPDB
Anti-KIT mAb NEG026
ADC Name Payload Target Linker ADC Info
Anti-KIT NEG026-SMCC-DM1 [2]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Anti-KIT NEG026-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
Anti-KIT NEG026-CX1-1-DM1 [2]
Mertansine DM1
Microtubule (MT)
2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)
Anti-KIT NEG026-SSNPP-DM3 [2]
Maytansinoid DM3
Microtubule (MT)
Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)
Anti-KIT NEG026-SPP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
Anti-KIT NEG026-SPDP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)
Anti-KIT NEG026 Sulfo-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
Sulfo-SPDB
Anti-KIT mAb NEG027
ADC Name Payload Target Linker ADC Info
Anti-KIT NEG027-SMCC-DM1 [2]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Anti-KIT NEG027-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
Anti-KIT NEG027-CX1-1-DM1 [2]
Mertansine DM1
Microtubule (MT)
2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)
Anti-KIT NEG027-SSNPP-DM3 [2]
Maytansinoid DM3
Microtubule (MT)
Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)
Anti-KIT NEG027-SPP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
Anti-KIT NEG027-SPDP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)
Anti-KIT NEG027 Sulfo-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
Sulfo-SPDB
Anti-KIT mAb NEG085
ADC Name Payload Target Linker ADC Info
Anti-KIT NEG085-SMCC-DM1 [2]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Anti-KIT NEG085-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
Anti-KIT NEG085-CX1-1-DM1 [2]
Mertansine DM1
Microtubule (MT)
2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)
Anti-KIT NEG085-SSNPP-DM3 [2]
Maytansinoid DM3
Microtubule (MT)
Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)
Anti-KIT NEG085-SPP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
Anti-KIT NEG085-SPDP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)
Anti-KIT NEG085 Sulfo-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
Sulfo-SPDB
Anti-KIT mAb NEG086
ADC Name Payload Target Linker ADC Info
Anti-KIT NEG086-SMCC-DM1 [2]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Anti-KIT NEG086-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
Anti-KIT NEG086-CX1-1-DM1 [2]
Mertansine DM1
Microtubule (MT)
2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)
Anti-KIT NEG086-SSNPP-DM3 [2]
Maytansinoid DM3
Microtubule (MT)
Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)
Anti-KIT NEG086-SPP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
Anti-KIT NEG086-SPDP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)
Anti-KIT NEG086 Sulfo-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
Sulfo-SPDB
Anti-KIT mAb NEG087
ADC Name Payload Target Linker ADC Info
Anti-KIT NEG087-SMCC-DM1 [2]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Anti-KIT NEG087-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
Anti-KIT NEG087-CX1-1-DM1 [2]
Mertansine DM1
Microtubule (MT)
2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)
Anti-KIT NEG087-SSNPP-DM3 [2]
Maytansinoid DM3
Microtubule (MT)
Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)
Anti-KIT NEG087-SPP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
Anti-KIT NEG087-SPDP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)
Anti-KIT NEG087 Sulfo-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
Sulfo-SPDB
ADC Name Payload Target Linker ADC Info
LOP628
DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
ADC Name Payload Target Linker ADC Info
NN3201
Monomethyl auristatin E
Microtubule (MT)
Bis-sulfone-(PEG24)-Glu-Val-Cit-PAB
NN2101-DM1 [5]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Opelkibart
ADC Name Payload Target Linker ADC Info
opelkibart elmanitin
α-amanitin
RNA polymerase II
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
NN-3901 [6]
Undisclosed
Undisclosed
Undisclosed
NN-3202 [7]
Undisclosed
Undisclosed
Undisclosed
C-Kit Antibody-drug conjugate (Novartis/ImmunoGen) [8]
Undisclosed
Undisclosed
Undisclosed
KTN0182A [9]
PBD dimer
Human Deoxyribonucleic acid (hDNA)
Undisclosed
CD117-ADC [10]
SG3199
Human Deoxyribonucleic acid (hDNA)
Mal-PEG8-Val-Ala-PABC
WO2024121632A1Formula la [11]
Undisclosed
Undisclosed
Undisclosed
References
Ref 1 Antibody-drug conjugates for removing hematopoietic stem cells
Ref 2 Antibody drug conjugates.
Ref 3 Antibody-immunotoxin Conjugate Using FcBP-mediated Photoconjugation to Treat Cancer. Anticancer Res. 2022 Jul;42(7):3453-3461. doi: 10.21873/anticanres.15832.
Ref 4 Antibody-Drug Conjugate Targeting c-Kit for the Treatment of Small Cell Lung Cancer. Int J Mol Sci. 2022 Feb 18;23(4):2264.
Ref 5 A novel anti-c-Kit antibody-drug conjugate to treat wild-type and activating-mutant c-Kit-positive tumors. Mol Oncol. 2022 Mar;16(6):1290-1308.
Ref 6 Novelty nobility attracts $9M in series a funding for NN2101 GLP tox studies; 2020
Ref 7 Introduction to basic information on ADC drug NN-3202.
Ref 8 Introduction to basic information on ADC drug C-Kit Antibody-drug conjugate (Novartis/ImmunoGen)
Ref 9 ADC review: basic information about KTN0182A.
Ref 10 Fertility-preserving myeloablative conditioning using single-dose CD117 antibody-drug conjugate in a rhesus gene therapy model
Ref 11 Use of anti-CD117 antibody-drug conjugate (ADC)